亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

[Impact of visceral pleural invasion on the prognosis of stage Ib non-small cell lung cancer].

医学 内科学 阶段(地层学) 比例危险模型 胃肠病学 多元分析 肺癌 存活率 生存分析 B组 癌症 肿瘤科 外科 生物 古生物学
作者
Xiao Dong Su,Hao Long,Xin Wang,Jianhua Fu,Jié He,Peng Lin,Lan Jun Zhang,Wei Guo
出处
期刊:PubMed 卷期号:30 (5): 368-71
链接
标识
摘要

To investigate the impact of visceral pleural invasion (VPI) on prognosis and staging in patients with stage Ib non-small cell lung cancer (NSCLC).Clinical data of 232 patients with stage Ib NSCLC surgically treated by curative resection between January 1994 and December 2003 was retrospectively reviewed. Histopathological diagnosis was reviewed by an experienced pathologist. According to the tumor size and status of VPI, patients were stratified into three group: group A: tumor > 3 cm and VPI(-); group B: tumor < or = 3 cm and VPI (+); group C: tumor > 3 cm and VPI(+). There were 45 patients in group A, 96 in group B and 91 in group C. Kaplan-Meier method was used for survival analysis. Cox proportional hazards model was used for multivariate analysis.187 (80.6%) patients had visceral plural invasion, while 45 (19.4%) had no. The 5-and 10-year survival rates of patients with VPI were 59.3% and 42.6%, while it was 70.1% and 56.7% for the patients without (P = 0.035), respectively. The 5-year survival rates of patients in group A, B and C were 70.1%, 61.9% and 56.2%; and 10-years survival rates were 56.7%, 50.6% and 35.9%, respectively (P = 0.018). VPI with large size of tumor was revealed by Cox multivariate analysis as an independent prognostic factor (RR = 1.530, 95% CI: 1.132-2.067, P = 0.006).A significant difference in survival exists among the stage Ib NSCLC patients who have different T status, the patient with > 3 cm tumor and visceral plural invasion may have the worst prognosis. Further studies are still needed to assess whether it is necessary or not to modify the T2 statue of tumor > 3 cm with visceral plural invasion.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
10秒前
roro熊完成签到 ,获得积分10
11秒前
dut杜完成签到 ,获得积分10
13秒前
沉默的谷丝完成签到,获得积分10
18秒前
20秒前
迷路翠萱完成签到 ,获得积分10
24秒前
小二郎应助科研通管家采纳,获得10
25秒前
花花123发布了新的文献求助10
26秒前
35秒前
CipherSage应助花花123采纳,获得10
36秒前
Anderson732发布了新的文献求助10
42秒前
47秒前
53秒前
落后的慕梅完成签到 ,获得积分10
1分钟前
wanghq发布了新的文献求助10
1分钟前
1nooooo完成签到 ,获得积分10
1分钟前
1分钟前
连长发布了新的文献求助10
1分钟前
1分钟前
gapper完成签到 ,获得积分10
1分钟前
AAAA发布了新的文献求助10
1分钟前
丘比特应助hahasun采纳,获得10
1分钟前
英俊的铭应助AAAA采纳,获得10
1分钟前
1分钟前
linglingling完成签到 ,获得积分10
1分钟前
1分钟前
2分钟前
大个应助bigalexwei采纳,获得10
2分钟前
Budoer发布了新的文献求助10
2分钟前
Lucas应助白灼虾采纳,获得10
2分钟前
斯文败类应助科研通管家采纳,获得10
2分钟前
2分钟前
乐乐应助YY采纳,获得10
2分钟前
2分钟前
赘婿应助Captain采纳,获得10
2分钟前
白灼虾发布了新的文献求助10
2分钟前
Budoer完成签到,获得积分20
2分钟前
2分钟前
bigalexwei发布了新的文献求助10
3分钟前
zcq完成签到 ,获得积分10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kinesiophobia : a new view of chronic pain behavior 2000
Psychology and Work Today 1000
Research for Social Workers 1000
Mastering New Drug Applications: A Step-by-Step Guide (Mastering the FDA Approval Process Book 1) 800
Signals, Systems, and Signal Processing 510
Discrete-Time Signals and Systems 510
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5907658
求助须知:如何正确求助?哪些是违规求助? 6794573
关于积分的说明 15768477
捐赠科研通 5031502
什么是DOI,文献DOI怎么找? 2709105
邀请新用户注册赠送积分活动 1658345
关于科研通互助平台的介绍 1602617